Two scientists from The Pirbright Institute attended the BBSRC Innovator of the Year Awards on 15 May 2019 as shortlisted finalists.
Pirbright scientists identify mutation hotspots that may inform infectious bronchitis vaccine development
Scientists at The Pirbright Institute have shown that infectious bronchitis virus (IBV) vaccines produced in eggs have unpredictable mutations which may be prone to reversion in the field. IBV causes a poultry disease which results in large economic losses across the globe.
The latest rounds of funding have proved successful with grants totalling more than £2.1 million awarded to scientists at The Pirbright Institute for research on virus and host characteristics. These studies will inform vaccine design and disease control for diseases that have a significant impact on animal and human health.
Recent funding awards include: